Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are essential for detecting viral RNA and triggering antiviral responses, including production of type I interferon. We analyzed the phenotype of non-synonymous mutantsofhumanRIG-IandMDA5reportedindatabasesbyfunctional complementation in cell cultures. Of seven missense mutations of RIG-I, S183I, which occurs within the second caspase recruitment domain repeat, inactivated this domain and conferred a dominant inhibitory function. Of 10 mutants of MDA5, two exhibited loss of function.Anonsense mutation, E627*, resulted in deletion of the C-terminal region and double-stranded RNA (dsRNA) binding activity. Another loss of function mutation, I923V, which occurs within the C-terminal domain, did not affect dsRNA binding activity, suggesting a novel and essential role for this residue in the signaling. Remarkably, these mutations are implicated in resistance to type I diabetes. However, the A946T mutation ofMDA5,which has been implicated in type I diabetes by previous genetic analyses, affected neither dsRNA binding nor IFN gene activation. These results provide new insights into the structure-function relationship of RIG-I-like receptors as well as into human RIG-I-like receptor polymorphisms, antiviral innate immunity, and autoimmune diseases. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.
CITATION STYLE
Shigemoto, T., Kageyama, M., Hirai, R., Zheng, J. P., Yoneyama, M., & Fujita, T. (2009). Identification of loss of function mutations in human genes encoding RIG-I and MDA5: Implications for resistance to type I diabetes. Journal of Biological Chemistry, 284(20), 13348–13354. https://doi.org/10.1074/jbc.M809449200
Mendeley helps you to discover research relevant for your work.